Unknown

Dataset Information

0

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

ABSTRACT: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer. This portion of the guidelines focuses on the management of localized disease, which involves careful patient selection for curative-intent treatment options that sequence multimodality therapy usually comprised of chemotherapy, radiation, and surgical resection.

SUBMITTER: Benson AB 

PROVIDER: S-EPMC10203817 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson Al B AB   Venook Alan P AP   Al-Hawary Mahmoud M MM   Cederquist Lynette L   Chen Yi-Jen YJ   Ciombor Kristen K KK   Cohen Stacey S   Cooper Harry S HS   Deming Dustin D   Engstrom Paul F PF   Grem Jean L JL   Grothey Axel A   Hochster Howard S HS   Hoffe Sarah S   Hunt Steven S   Kamel Ahmed A   Kirilcuk Natalie N   Krishnamurthi Smitha S   Messersmith Wells A WA   Meyerhardt Jeffrey J   Mulcahy Mary F MF   Murphy James D JD   Nurkin Steven S   Saltz Leonard L   Sharma Sunil S   Shibata David D   Skibber John M JM   Sofocleous Constantinos T CT   Stoffel Elena M EM   Stotsky-Himelfarb Eden E   Willett Christopher G CG   Wuthrick Evan E   Gregory Kristina M KM   Gurski Lisa L   Freedman-Cass Deborah A DA  

Journal of the National Comprehensive Cancer Network : JNCCN 20180701 7

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer. This portion of the guidelines focuses on the management of localized disease, which involves careful patient selection for curative-intent treatment options that sequence multimodality therapy usually comprised of chemot  ...[more]

Similar Datasets

Unknown Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10191161 | biostudies-literature
Unknown Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10203822 | biostudies-literature
Unknown Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC11807340 | biostudies-literature
Unknown Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10181270 | biostudies-literature
Unknown Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10186762 | biostudies-literature
Unknown Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC9440150 | biostudies-literature
Unknown NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
| S-EPMC10191771 | biostudies-literature
Unknown NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
| S-EPMC10184502 | biostudies-literature
Unknown NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
| S-EPMC10184498 | biostudies-literature
Unknown Breast cancer, version 3.2013: featured updates to the NCCN guidelines.
| S-EPMC3991132 | biostudies-literature